Evidence map›Paper›PMID 41296078›Full record

ArticleWorld journal of urology2025

Local recurrence after R0 partial nephrectomy for RCC: insights from a large multicenter cohort (PREPARE study - UroCCR 140).

Lucas Deluegue, Gaëlle Margue, Laurine Cadart, Jean-Christophe Bernhard, Karim Bensalah, Pierre Bigot, Nicolas Doumerc, Franck Bruyere, Morgan Roupret, Nicolas Branger and 18 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Lucas DeluegueUrology Department, Hôpital Claude Huriez, CHU Lille, Lille, France. lucasdeluegue@outlook.fr.
Gaëlle MargueUrology Department, CHU Bordeaux, Bordeaux, France.
Laurine CadartDepartment of Epidemiology and Biostatistics, CHU Lille, Lille, France.
Jean-Christophe BernhardUrology Department, CHU Bordeaux, Bordeaux, France.
Karim BensalahUrology Department, CHU Rennes, Rennes, France.
Pierre BigotUrology Department, CHU Anger, Anger, France.
Nicolas DoumercUrology Department, CHU Toulouse, Toulouse, France.
Franck BruyereUrology Department, CHU Tours, Tours, France.
Morgan RoupretUrology, GRC 5 Predictive Onco-Uro, AP-HP, Pitie-Salpetriere Hospital, Sorbonne University, Paris, F-75013, France.
Nicolas BrangerUrology Department, Institut Paoli Calmettes, Marseille, France.
Louis SurlemontUrology Department, CHU Rouen, Rouen, France.
Cécile ChampyUrology Department, CHU Henri Mondor, APHP, Creteil, France.
Bastient ParierUrology Department, Hôpital Bicêtre, APHP, Paris, France.
Philippe PaparelUrology Department, CHU Lyon Sud - Hospices Civils de Lyon, Lyon, France.
Thibaut WaeckelUrology Department, CHU Caen, Caen, France.
Hervé LangUrology Department, CHU Strasbourg, Strasbourg, France.
Constance MichelUrology Department, Hôpital privé St Joseph, Paris, France.
Alexis FontenilUrology Department, CHU Nîmes, Nîmes, France.
Jean-Baptiste BeauvalUrology Department, Clinique la croix du sud, Toulouse, France.
Jean-Jacques PatardUrology Department, CH Mont de Marsant, Mont de Marsant, France.
Maxime ValleeUrology Department, CHU Poitiers, Poitiers, France.
Julien GuillotreauUrology Department, Clinique Pasteur, Toulouse, France.
Olivier TraxerUrology Department, Hôpital Tenon, APHP, Paris, France.
Laurent GuyUrology Department, CHU Clermont-Ferrand, Clermont-Ferrand, France.
François AudenetUrology Department, Hôpital Européen Georges Pompidou, APHP, Paris, France.
Benjamin RougetUrology Department, CH Libourne, Libourne, France.
Jonathan OlivierUrology Department, Hôpital Claude Huriez, CHU Lille, Lille, France.
Jean-Christophe FantoniUrology Department, Hôpital Claude Huriez, CHU Lille, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLocal recurrence after partial nephrectomy with negative margins (R0) remains a clinical concern in the management of non-metastatic renal cell carcinoma (RCC). We aimed to quantify its incidence and to identify independent predictors of recurrence in a large, contemporary, multicenter cohort.

methodsWe retrospectively analyzed 2,438 patients from the UroCCR database who underwent R0 nephron-sparing surgery for cT1–cT3a/N0/M0 RCC between 2007 and 2022 across 24 French centers. The primary endpoint was histologically confirmed local recurrence (tumor bed or ipsilateral renal recurrence). Fine‑and‑Gray competing‑risk regression, with death treated as a competing event, was applied to determine independent predictors.

resultsAfter a median follow-up of 66 months (IQR:26–86), local recurrence occurred in 97 patients (3.9%). Independent predictors included open surgery (sHR 2.25 [95% CI, 1.02–4.97]), intraoperative complications (sHR 4.00 [95% CI, 1.65–9.68]), longer delay between diagnosis and surgery (sHR 1.02 [95% CI, 1.003–1.04]), clear cell histology (sHR 4.12 [2.18–7.79]), higher RENAL score, vascular emboli (sHR 3.90 [95% CI, 1.67–9.08]), and tumor necrosis (sHR 2.62 [95% CI, 1.54–4.47]). Robotic assistance was associated with a reduced recurrence risk (sHR 0.50 [95% CI, 0.28–0.88]).

conclusionLocal recurrence after R0 partial nephrectomy, though infrequent, is associated with clinical, surgical, and pathological factors. Open surgery, intra‑operative complications, treatment delay, tumor complexity, vascular emboli, necrosis and clear‑cell histology were correlated with an increase risk of recurrence.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNeoplasm Recurrence, LocalNephrectomyAgedCohort StudiesFemaleFranceHumansIncidenceMaleMiddle AgedRetrospective StudiesBiopsyLocal recurrenceNegative marginNephron sparing surgeryPartial nephrectomy.Renal cell carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.